Follow RSS for latest reports on this topicTransthyretin-Mediated Amyloidosis - Market Research and Reports

Transthyretin - Pipeline Review, H2 2020

Transthyretin - Pipeline Review, H2 2020SummaryAccording to the recently published report 'Transthyretin - Pipeline Review, H2 2020'; Transthyretin (ATTR or Prealbumin or TBPA or TTR) pipeline Target constitutes close to 16 molecules. Out of which approximately 14 molecules are developed by companies and remaining by the universities/institutes. Transthyretin (ATTR or Prealbumin or TBPA or TTR) - ...Read More >>>

Published:
2020-11-30

Published by: Global Markets Direct

Prices Starting From:
$2975

Amyloidosis - Pipeline Review, H2 2020

Amyloidosis - Pipeline Review, H2 2020SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Amyloidosis - Pipeline Review, H2 2020, provides an overview of the Amyloidosis (Metabolic Disorders) pipeline landscape.Abnormal accumulation of amyloid protein in the tissues results in a group of diseases known as amyloidosis. It may affect the shape and functioning o...Read More >>>

Published:
2020-07-31

Published by: Global Markets Direct

Prices Starting From:
$1700

Amyloidosis Global Clinical Trials Review, H2, 2020

Amyloidosis Global Clinical Trials Review, H2, 2020SummaryGlobalData's clinical trial report, “Amyloidosis Global Clinical Trials Review, H2, 2020 provides an overview of Amyloidosis Clinical trials scenario. This report provides top line data relating to the clinical trials on Amyloidosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted acro...Read More >>>

Published:
2020-07-06

Published by: Global Data

Prices Starting From:
$2125

Amyloidosis - Epidemiology Forecast to 2029

Amyloidosis - Epidemiology Forecast to 2029SummaryAmyloidosis is a rare disease characterized by extracellular and/or intracellular deposition of insoluble abnormal amyloid fibrils that alters the normal functions of the tissues in the organs (Holmes et al., 2019; Mayo Clinic, 2020). Amyloid is not normally found in the body, but it can be formed from several different types of protein and interfe...Read More >>>

Published:
2020-06-30

Published by: Global Data

Prices Starting From:
$3396

Transthyretin Amyloidosis - Global Drug Forecast and Market Analysis to 2029

Transthyretin Amyloidosis - Global Drug Forecast and Market Analysis to 2029SummaryAmyloidosis is a protein confirmation disorder that results in the build-up of insoluble amyloid proteins in tissues. This build-up can be fatal as it leads to disruption of organ systems and causes oxidative stress within the body. There are various forms of amyloidosis, each associated with the protein involved an...Read More >>>

Published:
2020-06-30

Published by: Global Data

Prices Starting From:
$9346

Transthyretin Amyloidosis - Pipeline Review-2056

Firstview Insight's Transthyretin Amyloidosis - Pipeline Review-2056 provides an overview of the pipeline landscape of Transthyretin Amyloidosis It provides comprehensive insights of all the clinical and non-clinical therapeutics in development with detailed description about the collaborations; deals; designations; patent information etc.These reports encourage the clients in distinguishing the ...Read More >>>

Published:
2019-12-27

Published by: First View Insight

Prices Starting From:
$1063

Transthyretin Amyloidosis - Pricing & Market Access and Landscape- 2056

Firstview Insight's Transthyretin Amyloidosis - Pricing & Market Access and Landscape- 2056 provides country specific insights in order to estimate market potential for Transthyretin Amyloidosis based on the pricing and reimbursement scenario and perceived value drivers in different market archetypes. It gives a detailed picture of the disease landscape and unmet needs of different stakeholders ...Read More >>>

Published:
2019-12-27

Published by: First View Insight

Prices Starting From:
$2125

Transthyretin Amyloidosis - Market Review, Epidemiology And Market Forecast - 2066

FirstView Market Insight Transthyretin Amyloidosis - Market Review, Epidemiology And Market Forecast - 2066 provides in depth understanding of historical and forecasted epidemiology along with the detailed market insights.The report covers detailed information on the disease, treatment algorithm, existing treatment and upcoming treatment regimens, unmet needs, market drivers, market barriers, sal...Read More >>>

Published:
2019-12-27

Published by: First View Insight

Prices Starting From:
$2975

Transthyretin - Pipeline Review, H2 2019

Transthyretin - Pipeline Review, H2 2019SummaryTransthyretin (ATTR or Prealbumin or TBPA or TTR) pipeline Target constitutes close to 17 molecules. Out of which approximately 16 molecules are developed by companies and remaining by the universities/institutes. The latest report Transthyretin - Pipeline Review, H2 2019, outlays comprehensive information on the Transthyretin (ATTR or Prealbumin or T...Read More >>>

Published:
2019-12-27

Published by: Global Markets Direct

Prices Starting From:
$2975

Amyloidosis - Pipeline Review, 2019

Firstview Insight's Amyloidosis - Pipeline Review, 2019 provides an overview of the pipeline landscape of Amyloidosis It provides comprehensive insights of all the clinical and non-clinical therapeutics in development with detailed description about the collaborations; deals; designations; patent information etc.These reports encourage the clients in distinguishing the upcoming and existing compe...Read More >>>

Published:
2019-11-15

Published by: First View Insight

Prices Starting From:
$1063

Amyloidosis - Pricing and Market Access

Firstview Insight's Amyloidosis - Pricing and Market Access provides country specific insights in order to estimate market potential for Amyloidosis based on the pricing and reimbursement scenario and perceived value drivers in different market archetypes. It gives a detailed picture of the disease landscape and unmet needs of different stakeholders existing in the current treatment paradigmThus...Read More >>>

Published:
2019-11-15

Published by: First View Insight

Prices Starting From:
$2125

Amyloidosis - Market Review, Epidemiology And Market Forecast - 2029

FirstView Market Insight Amyloidosis - Market Review, Epidemiology And Market Forecast - 2029 provides in depth understanding of historical and forecasted epidemiology along with the detailed market insights.The report covers detailed information on the disease, treatment algorithm, existing treatment and upcoming treatment regimens, unmet needs, market drivers, market barriers, sales trend and m...Read More >>>

Published:
2019-11-15

Published by: First View Insight

Prices Starting From:
$2975

Amyloidosis - Pipeline Review, H2 2019

Amyloidosis - Pipeline Review, H2 2019SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Amyloidosis - Pipeline Review, H2 2019, provides an overview of the Amyloidosis (Metabolic Disorders) pipeline landscape.Abnormal accumulation of amyloid protein in the tissues results in a group of diseases known as amyloidosis. It may affect the shape and functioning o...Read More >>>

Published:
2019-11-11

Published by: Global Markets Direct

Prices Starting From:
$1700

Targeting Transthyretin Amyloidosis Pipeline Drugs: Opportunity Assessments, Epidemiology Forecast, Market Dynamics and Pipeline Analysis H2 2020

GervanoRA’s Pipeline Drug Analytics Report Targeting Transthyretin Amyloidosis Pipeline Drugs: Opportunity Assessments, Epidemiology Forecast, Market Dynamics and Pipeline Analysis H2 2020 provides a detailed overview on Targeting Transthyretin Amyloidosis Competitive Space. Report provides deep insights on pipeline analytics outlook, drivers, restraints and unmet needs of Targeting Transthyre...Read More >>>

Published:
2019-08-20

Published by: Gervano R A

Prices Starting From:
$1063

Amyloidosis Pipeline Drugs: Opportunity Assessments, Epidemiology Forecast, Market Dynamics and Pipeline Analysis H2 2020

GervanoRA’s Pipeline Drug Analytics Report Amyloidosis Pipeline Drugs: Opportunity Assessments, Epidemiology Forecast, Market Dynamics and Pipeline Analysis H2 2020 provides a detailed overview on Amyloidosis Competitive Space. Report provides deep insights on pipeline analytics outlook, drivers, restraints and unmet needs of Amyloidosis pipeline drugs, Pipeline Analytics, Epidemiological Stud...Read More >>>

Published:
2019-08-15

Published by: Gervano R A

Prices Starting From:
$1063

2019 Primary Systemic Amyloidosis Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

The global clinical trial report- “2019 Primary Systemic Amyloidosis Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Primary Systemic Amyloidosis. It presents in-depth analysis of Primary Systemic Amyloidosis clinical trials across markets and companies. The research work is for providing complete understanding into trends in Primary Systemic Amyloid...Read More >>>

Published:
2019-04-24

Published by: VPA Research

Prices Starting From:
$1529

2019 Amyloidosis Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

The global clinical trial report- “2019 Amyloidosis Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Amyloidosis. It presents in-depth analysis of Amyloidosis clinical trials across markets and companies. The research work is for providing complete understanding into trends in Amyloidosis. The report covers a key snapshot of trial trends, enrollment t...Read More >>>

Published:
2019-04-24

Published by: VPA Research

Prices Starting From:
$1529

Amyloidosis - Pipeline Drugs and Companies, Q2 2019

Summary Amyloidosis pipeline research report is a part of our 300+ Pharmaceutical and Healthcare disease pipeline report series. It provides detailed insights into Amyloidosis R&D activities including pipeline candidates, grants, developments, investments, technological advancements, and progress.Extensive Coverage of Pipeline CandidatesThe Amyloidosis report covers all the pre-clinical compounds ...Read More >>>

Published:
2019-04-08

Published by: VPA Research

Prices Starting From:
$1529

Amyloidosis Global Clinical Trials Review, H2, 2018

Amyloidosis Global Clinical Trials Review, H2, 2018SummaryGlobalData's clinical trial report, “Amyloidosis Global Clinical Trials Review, H2, 2018 provides an overview of Amyloidosis clinical trials scenario. This report provides top line data relating to the clinical trials on Amyloidosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted acro...Read More >>>

Published:
2018-10-31

Published by: Global Data

Prices Starting From:
$2125

Transthyretin (ATTR or Prealbumin or TBPA or TTR) - Pipeline Review, H2 2018

Transthyretin (ATTR or Prealbumin or TBPA or TTR) - Pipeline Review, H2 2018SummaryTransthyretin (ATTR or Prealbumin or TBPA or TTR) - Transthyretin is a transport protein. It transports thyroid hormones in the plasma and cerebrospinal fluid, and also transports retinol (vitamin A) in the plasma. The diseases caused by mutations include amyloidotic polyneuropathy, euthyroid hyperthyroxinaemia, amy...Read More >>>

Published:
2018-10-16

Published by: Global Markets Direct

Prices Starting From:
$2975

Amyloidosis - Pipeline Review, H2 2018

Amyloidosis - Pipeline Review, H2 2018SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Amyloidosis - Pipeline Review, H2 2018, provides an overview of the Amyloidosis (Metabolic Disorders) pipeline landscape.Abnormal accumulation of amyloid protein in the tissues results in a group of diseases known as amyloidosis. It may affect the shape and functioning o...Read More >>>

Published:
2018-07-17

Published by: Global Markets Direct

Prices Starting From:
$1700

Primary Systemic Amyloidosis Global Clinical Trials Review, H1, 2018

Primary Systemic Amyloidosis Global Clinical Trials Review, H1, 2018SummaryGlobalData's clinical trial report, “Primary Systemic Amyloidosis Global Clinical Trials Review, H1, 2018 provides an overview of Primary Systemic Amyloidosis clinical trials scenario. This report provides top line data relating to the clinical trials on Primary Systemic Amyloidosis. Report includes an overview of trial ...Read More >>>

Published:
2018-06-29

Published by: Global Data

Prices Starting From:
$2125

Transthyretin (ATTR or Prealbumin or TBPA or TTR) - Pipeline Review, H1 2018

Transthyretin (ATTR or Prealbumin or TBPA or TTR) - Pipeline Review, H1 2018SummaryTransthyretin (ATTR or Prealbumin or TBPA or TTR) - Transthyretin is a transport protein. It transports thyroid hormones in the plasma and cerebrospinal fluid, and also transports retinol (vitamin A) in the plasma.The diseases caused by mutations include amyloidotic polyneuropathy, euthyroid hyperthyroxinaemia, amyl...Read More >>>

Published:
2018-04-17

Published by: Global Markets Direct

Prices Starting From:
$2975

Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) - Pipeline Insight, 2018

Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) - Pipeline Insight, 2018” report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) development. The report provides detailed coverage of t...Read More >>>

Published:
2018-02-14

Published by: Delve Insight

Prices Starting From:
$1063

Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018

IntroductionDelveInsight's, “Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018 report provides comprehensive insights about marketed and Phase III products for Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) . The report includes information o...Read More >>>

Published:
2018-02-14

Published by: Delve Insight

Prices Starting From:
$1700

Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) - Epidemiology Forecast to 2027

DelveInsight's Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) - Epidemiology Forecast, 2027” report provides a comprehensive analysis of the Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2027. Markets...Read More >>>

Published:
2018-02-14

Published by: Delve Insight

Prices Starting From:
$2763

Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) - Market Insight, Epidemiology and Market Forecast - 2027

DelveInsight's Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) - Market Insight, Epidemiology and Market Forecast - 2027 report provides a detailed analysis of the Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) epidemiology and market outlook for the 7MM.Markets Covered• United States• EU5 (Germany, France, ...Read More >>>

Published:
2018-02-14

Published by: Delve Insight

Prices Starting From:
$5313

Global and Chinese Amyloidosis Therapeutics Industry, 2017 Market Research Report

The 'Global and Chinese Amyloidosis Therapeutics Industry, 2012-2022 Market Research Report' is a professional and in-depth study on the current state of the global Amyloidosis Therapeutics industry with a focus on the Chinese market. The report provides key statistics on the market status of the Amyloidosis Therapeutics manufacturers and is a valuable source of guidance and direction for companie...Read More >>>

Published:
2017-12-24

Published by: Prof Research

Prices Starting From:
$2550

Transthyretin (ATTR or Prealbumin or TBPA or TTR) - Pipeline Review, H2 2017

Transthyretin (ATTR or Prealbumin or TBPA or TTR) - Pipeline Review, H2 2017SummaryAccording to the recently published report 'Transthyretin (ATTR or Prealbumin or TBPA or TTR) - Pipeline Review, H2 2017'; Transthyretin (ATTR or Prealbumin or TBPA or TTR) pipeline Target constitutes close to 15 molecules. Out of which approximately 12 molecules are developed by companies and remaining by the unive...Read More >>>

Published:
2017-10-10

Published by: Global Markets Direct

Prices Starting From:
$2975

Amyloidosis - Pipeline Review, H2 2017

Amyloidosis - Pipeline Review, H2 2017SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Amyloidosis - Pipeline Review, H2 2017, provides an overview of the Amyloidosis (Metabolic Disorders) pipeline landscape.Abnormal accumulation of amyloid protein in the tissues results in a group of diseases known as amyloidosis. It may affect the shape and functioning o...Read More >>>

Published:
2017-07-18

Published by: Global Markets Direct

Prices Starting From:
$1700

Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) - Pipeline Insight, 2017

DelveInsight’s, “ Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) -Pipeline Insights, 2017”, report provides comprehensive insights about pipeline drugs across this Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease). The key objective of the report is to establish the understanding for all the pipeline drugs that ...Read More >>>

Published:
2017-07-10

Published by: Delve Insight

Prices Starting From:
$1063

Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) - Market Insights, Epidemiology and Market Forecast – 2025

DelveInsight’s “Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) - Market Insights, Epidemiology and Market Forecast – 2025” Reports provides an overview of the disease and global market size of the Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) for the 7MM (United States, Germany, France, Italy, Spain and UK...Read More >>>

Published:
2017-07-10

Published by: Delve Insight

Prices Starting From:
$4888

Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) - Epidemiology Insights to 2025

DelveInsight “ Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) - Epidemiology Forecast To 2025” provides an overview of the epidemiology trends of Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical ...Read More >>>

Published:
2017-07-10

Published by: Delve Insight

Prices Starting From:
$2508

Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

DelveInsight’s, Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017” report provides comprehensive insights about marketed and Phase III products for the Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease). The report includes information of market...Read More >>>

Published:
2017-07-01

Published by: Delve Insight

Prices Starting From:
$1700

Amyloidosis Global Clinical Trials Review, H1, 2017

Amyloidosis Global Clinical Trials Review, H1, 2017SummaryGlobalData's clinical trial report, “Amyloidosis Global Clinical Trials Review, H1, 2017 provides an overview of Amyloidosis clinical trials scenario. This report provides top line data relating to the clinical trials on Amyloidosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted acro...Read More >>>

Published:
2017-03-31

Published by: Global Data

Prices Starting From:
$2125

Amyloidosis - Pipeline Review, H1 2017

Amyloidosis - Pipeline Review, H1 2017SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Amyloidosis - Pipeline Review, H1 2017, provides an overview of the Amyloidosis (Metabolic Disorders) pipeline landscape.Abnormal accumulation of amyloid protein in the tissues results in a group of diseases known as amyloidosis. It may affect the shape and functioning o...Read More >>>

Published:
2017-02-28

Published by: Global Markets Direct

Prices Starting From:
$1700

Transthyretin (ATTR or Prealbumin or TBPA or TTR) - Pipeline Review, H2 2016

Transthyretin (ATTR or Prealbumin or TBPA or TTR) - Pipeline Review, H2 2016SummaryGlobal Markets Direct’s, ‘Transthyretin (ATTR or Prealbumin or TBPA or TTR) - Pipeline Review, H2 2016’, provides in depth analysis on Transthyretin (ATTR or Prealbumin or TBPA or TTR) targeted pipeline therapeutics. The report provides comprehensive information on the Transthyretin (ATTR or Prealbumin or TBPA...Read More >>>

Published:
2016-10-26

Published by: Global Markets Direct

Prices Starting From:
$2975

Primary Systemic Amyloidosis Global Clinical Trials Review, H1, 2016

Primary Systemic Amyloidosis Global Clinical Trials Review, H1, 2016SummaryGlobalData's clinical trial report, “Primary Systemic Amyloidosis Global Clinical Trials Review, H1, 2016 provides an overview of Primary Systemic Amyloidosis clinical trials scenario. This report provides top line data relating to the clinical trials on Primary Systemic Amyloidosis. Report includes an overview of trial ...Read More >>>

Published:
2016-06-30

Published by: Global Data

Prices Starting From:
$2125

Amyloidosis Global Clinical Trials Review, H1, 2016

Amyloidosis Global Clinical Trials Review, H1, 2016SummaryGlobalData's clinical trial report, “Amyloidosis Global Clinical Trials Review, H1, 2016 provides an overview of Amyloidosis clinical trials scenario. This report provides top line data relating to the clinical trials on Amyloidosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted acro...Read More >>>

Published:
2016-05-31

Published by: Global Data

Prices Starting From:
$2125